A Four-Part Study to Assess the Safety, Tolerability, PK and PD of ONO-5788 in Healthy Adult Volunteers

Condition:   Acromegaly Interventions:   Drug: ONO-5788;   Drug: ONO-5788 Placebo;   Drug: Octreotide;   Drug: Octreotide Placebo Sponsor:   Ono Pharmaceutical Co. Ltd Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Acromegaly | Study